Keyphrases
Confidence Interval
100%
Systematic Meta-analysis
85%
Retrospective Cohort Study
76%
Israel
74%
Meta-analysis
65%
COVID-19
63%
Hazard Ratio
61%
Older Adults
52%
Immunohistochemical Staining
51%
Risk Factors
49%
Mismatch Repair Proteins
46%
Population-based Study
44%
Israeli
44%
Clinical Outcomes
42%
Biopsy Specimen
42%
Endoscopic Biopsy
42%
Clostridium Difficile Infection
42%
Colorectal Cancer
42%
Proton Pump Inhibitors
42%
Randomized Controlled Trial
34%
COVID-19 Pandemic
31%
Hip Fracture
29%
Helicobacter Pylori (H. pylori)
28%
Long-term Mortality
27%
Long-term Survival
27%
Liver Transplantation
26%
MLH1
25%
Colon Cancer
25%
Socioeconomic Status
25%
Dementia
25%
Older Patients
25%
Meta-analysis of Randomized Controlled Trials
24%
Body Mass Index
23%
Helicobacter Pylori Infection
23%
Low-grade Dysplasia
23%
Frail Elderly
23%
Anemia
23%
Orthopedic Department
21%
Colistin
21%
Diminutive
21%
Molecular Diagnostics
21%
Celiac Disease
21%
Prevalence Trends
21%
Dose Effect
21%
Follow-up Colonoscopy
21%
Bedouin Arabs
21%
Immunosuppressed Population
21%
Increased BMI
21%
Hip Fracture Patients
21%
Gastric Intestinal Metaplasia
21%
Medicine and Dentistry
Systematic Review
85%
Retrospective Cohort Study
73%
COVID-19
69%
Infection
67%
Meta-Analysis
63%
Hazard Ratio
54%
Severe Acute Respiratory Syndrome Coronavirus 2
46%
Hip Fracture
42%
Endoscopic Biopsy
42%
Immunohistochemistry
42%
Liver Transplantation
42%
Clostridium Difficile Infection
42%
Mismatch Repair Protein
42%
Randomized Controlled Trial
31%
Long Term Survival
28%
Geriatrics
27%
Neoplasm
25%
Retrospective Study
25%
Colon Carcinoma
24%
Body Mass Index
23%
Dysplasia
23%
Functional Independence Measure
23%
Geriatric Rehabilitation
21%
Rehabilitation Center
21%
Disease Course
21%
Rectum Cancer
21%
Intestinal Metaplasia
21%
Orthopedics
21%
Drug Megadose
21%
Helicobacter Pylori
21%
Proton-Pump Inhibitor
21%
Social Isolation
21%
Avibactam Plus Ceftazidime
21%
Colistimethate
21%
Diagnosis of Clostridium Difficile
21%
Cotransporter
21%
Bloodstream Infection
21%
Tubular Adenoma
21%
Influenza Vaccine
21%
Polypectomy
21%
Anemia
21%
Colonoscopy
21%
Internal Medicine
21%
Model For End Stage Liver Disease Score
21%
Polymerase Chain Reaction
21%
Neutralizing Antibody
21%
Prospective Cohort Study
21%
West Nile Virus
21%
Adverse Event
21%
Acute Kidney Injury
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
67%
Randomized Controlled Trial
53%
Clostridium Difficile Infection
42%
SARS Coronavirus
42%
Antibiotics
28%
Cohort Study
28%
Adverse Event
23%
Anemia
23%
Colistimethate
21%
Cholera
21%
Rectum Cancer
21%
Prevalence
21%
Helicobacter Infection
21%
Antiinfective Agent
21%
Chloramphenicol
21%
Disease Course
21%
Avibactam Plus Ceftazidime
21%
Bloodstream Infection
21%
Coeliac Disease
21%
Retrospective Study
21%
Helicobacter Pylori
21%
Colon Carcinoma
21%
Live Attenuated Influenza Vaccine
21%
Prospective Cohort Study
21%
Neutralizing Antibody
21%
Proton Pump Inhibitor
21%
Tetracycline
17%
Diarrhea
17%
Immunoassay
15%
Cognitive Defect
14%
Immunocompromised Patient
14%
Diseases
11%
All Cause Mortality
11%
Observational Study
10%
Malignant Neoplasm
10%
Placebo
10%
Frailty
10%
Infectious Agent
9%
Albumin
9%
Coronavirinae
8%
Pandemic
8%
Acute Kidney Failure
7%
Sepsis
7%
Underweight
7%
Urease
7%
Carbon 13
7%
Influenza A Virus (H3N2)
7%
Doxycycline
7%
Norfloxacin
7%
Antimicrobial Therapy
7%